# Evaluation of the Effect in Platelet Count of Atorvastatin and N-acetyl Cysteine

> **NCT05551624** · EARLY_PHASE1 · COMPLETED · sponsor: **Hospital Civil de Guadalajara** · enrollment: 15 (actual)

## Conditions studied

- Primary Immune Thrombocytopenia

## Interventions

- **DRUG:** Atorvastatin 40 Mg Oral Tablet + N-acetylcysteine 400 mg Oral tablet

## Key facts

- **NCT ID:** NCT05551624
- **Lead sponsor:** Hospital Civil de Guadalajara
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-07-04
- **Primary completion:** 2019-12-11
- **Final completion:** 2020-01-23
- **Target enrollment:** 15 (ACTUAL)
- **Last updated:** 2022-09-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05551624

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05551624, "Evaluation of the Effect in Platelet Count of Atorvastatin and N-acetyl Cysteine". Retrieved via AI Analytics 2026-07-25 from https://api.ai-analytics.org/clinical/NCT05551624. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*